A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTION

被引:1
|
作者
Rao, S. [1 ]
Lin, F. J. [1 ]
Ojo, O. [1 ]
Patel, V [1 ]
Yu, S. [1 ]
Zhan, L. [1 ]
Touchette, D. R. [1 ]
机构
[1] Univ Illinois, Chicago, IL USA
关键词
D O I
10.1016/j.jval.2011.02.229
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A39 / A40
页数:2
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS OF TICAGRELOR VERSUS GENERIC CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES IN CANADA
    Grima, D. T.
    Brown, S. T.
    Kamboj, L.
    Bainey, K.
    Goeree, R.
    Oh, P.
    Ramanathan, K.
    Goodman, S.
    VALUE IN HEALTH, 2013, 16 (03) : A285 - A285
  • [32] COST-EFFECTIVENESS ANALYSIS OF INTRAVASCULAR ULTRASOUND IN PERCUTANEOUS CORONARY INTERVENTION
    Lao, Y.
    Zhong, W.
    Yang, L.
    VALUE IN HEALTH, 2022, 25 (01) : S92 - S92
  • [33] COST-EFFECTIVENESS OF PERCUTANEOUS CORONARY INTERVENTION FOR STABLE ANGINA IN JAPAN
    Kodera, S.
    VALUE IN HEALTH, 2018, 21 : S31 - S31
  • [34] Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
    Wisloff, Torbjorn
    Atar, Dan
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2016, 2 (01) : 52 - 57
  • [35] Efficacy and Safety of Prasugrel Compared With Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Wang, Amy
    Lella, Leela K.
    Brener, Sorin J.
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (06) : E1637 - E1643
  • [36] Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    张步春
    车文良
    刘伟静
    徐亚伟
    South China Journal of Cardiology, 2010, 11 (04) : 238 - 245
  • [37] Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction
    Selmer, R
    Halvorsen, S
    Myhre, KI
    Wisloff, TF
    Kristiansen, IS
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2005, 39 (05) : 276 - 285
  • [38] A cost-effectiveness analysis of fluvastatin in patients with diabetes after successful percutaneous coronary intervention
    Scuffham, PA
    Chaplin, S
    CLINICAL THERAPEUTICS, 2005, 27 (09) : 1467 - 1477
  • [39] The Cost-Effectiveness of Percutaneous Coronary Intervention as a Function of Angina Severity in Patients With Stable Angina
    Zhang, Zugui
    Kolm, Paul
    Boden, William E.
    Hartigan, Pamela M.
    Maron, David J.
    Spertus, John A.
    O'Rourke, Robert A.
    Shaw, Leslee J.
    Sedlis, Steven P.
    Mancini, G. B. John
    Berman, Daniel S.
    Dada, Marcin
    Teo, Koon K.
    Weintraub, William S.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (02): : 172 - U72
  • [40] Cost-effectiveness of Radial Access Percutaneous Coronary Intervention in Acute Coronary Syndrome
    Lee, Peter
    Liew, Danny
    Brennan, Angela
    Stub, Dion
    Lefkovits, Jeffrey
    Reid, Christopher M.
    Zomer, Ella
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 156 : 44 - 51